|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-10
|
|
pubmed:abstractText |
Quadruple therapy is generally recommended as second-line therapy after Helicobacter pylori (H. pylori) eradication failure. However, this regimen requires the administration of four drugs with a complex scheme, is associated with a relatively high incidence of adverse effects, and bismuth salts are not available worldwide anymore. Our aim was to evaluate the efficacy and tolerability of a triple second-line levofloxacin-based regimen in patients with H. pylori eradication failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
pubmed-author:AlmelaPedroP,
pubmed-author:BarrioJoséJ,
pubmed-author:BenitoLuis-MiguelLM,
pubmed-author:BermejoFernandoF,
pubmed-author:BoryFelipeF,
pubmed-author:CalvetXavierX,
pubmed-author:CarnerosJose-AntonioJA,
pubmed-author:Castro-FernándezManuelM,
pubmed-author:CosmeAngelA,
pubmed-author:Fernández-BermejoMiguelM,
pubmed-author:FrancoAlejandroA,
pubmed-author:García-DuránFernandoF,
pubmed-author:GisbertJavier PJP,
pubmed-author:H. pylori Study Group of the Asociación Española de Gastroenterología,
pubmed-author:KhorramiSamS,
pubmed-author:LamasEloisaE,
pubmed-author:ModolellInésI,
pubmed-author:NiñoPilarP,
pubmed-author:O'CallaghanElenaE,
pubmed-author:OrtizVicenteV,
pubmed-author:OrtuñoJuanJ,
pubmed-author:Pérez-AisaAngelesA,
pubmed-author:PonceJulioJ,
pubmed-author:RodrigoLuisL,
pubmed-author:Sánchez-PobrePilarP,
pubmed-author:TomasAlbertA,
pubmed-author:ValerMaría-PazMP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
71-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17764498-Amoxicillin,
pubmed-meshheading:17764498-Anti-Bacterial Agents,
pubmed-meshheading:17764498-Breath Tests,
pubmed-meshheading:17764498-Clarithromycin,
pubmed-meshheading:17764498-Drug Therapy, Combination,
pubmed-meshheading:17764498-Endoscopy, Gastrointestinal,
pubmed-meshheading:17764498-Female,
pubmed-meshheading:17764498-Follow-Up Studies,
pubmed-meshheading:17764498-Gastric Mucosa,
pubmed-meshheading:17764498-Helicobacter Infections,
pubmed-meshheading:17764498-Helicobacter pylori,
pubmed-meshheading:17764498-Humans,
pubmed-meshheading:17764498-Male,
pubmed-meshheading:17764498-Middle Aged,
pubmed-meshheading:17764498-Ofloxacin,
pubmed-meshheading:17764498-Omeprazole,
pubmed-meshheading:17764498-Prospective Studies,
pubmed-meshheading:17764498-Proton Pump Inhibitors,
pubmed-meshheading:17764498-Treatment Failure,
pubmed-meshheading:17764498-Urea
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
|
|
pubmed:affiliation |
Hospital de la Princesa, Madrid.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
